ASX Announcements

Neuren announces new US patent to be granted for NNZ-2591
Consolidation/Split - NEU
Notification under Listing Rule 7.20 of share reorganisation
Appendix 4C - quarterly
Neuren FDA meeting confirms Phase 3 plan for Rett syndrome
Investor presentation, 6 October 2017
Presentations and publication for Rett syndrome trials
Change of Director's Interest Notice
Change of Director's Interest Notice
Change of Director's Interest Notice